1. New strategies for targeting drug combinations to overcome mutation-driven drug resistance
   Linyan Wang et al, 2017, Seminars in Cancer Biology CrossRef
2. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway
   Hui Shi et al, 2017, Tumor Biology CrossRef
3. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway
   Wencui Kong et al, 2020, International Journal of Molecular Medicine CrossRef
4. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer
   Maolan Li et al, 2016, Oncotarget CrossRef
5. RETRACTED ARTICLE: Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21
   Qing Yang et al, 2019, Molecular and Cellular Biochemistry CrossRef
6. Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells
   Rui-Ping Ye et al, 2017, Xenobiotica CrossRef
7. Role of c-Src in Carcinogenesis and Drug Resistance
   Lukmon Raji et al, 2023, Cancers CrossRef
8. Doxorubicin-induced toxicity to 3D-cultured rat ovarian follicles on a microfluidic chip
   Aziz ur Rehman Aziz et al, 2020, Toxicology in Vitro CrossRef
9. Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
   Tijana Stanković et al, 2019, Current Medicinal Chemistry CrossRef
10. Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advances
    Sven Marcel Stefan et al, 2019, Medicinal Research Reviews CrossRef
11. Rack1 mediates Src binding to drug transporter P-glycoprotein and modulates its activity through regulating Caveolin-1 phosphorylation in breast cancer cells
    Yanling Fan et al, 2019, Cell Death & Disease CrossRef
12. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation
    Sang-Hyun Lee et al, 2021, Cell Death & Differentiation CrossRef
13. Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations
    Yong-Xia Bao et al, 2016, Cellular Oncology CrossRef
14. Bioinformatic mining of kinase inhibitors that regulate autophagy through kinase signaling pathways
    YANG YANG et al, 2014, Molecular Medicine Reports CrossRef
15. Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity
    S Hu et al, 2017, Clinical and Translational Science CrossRef